Castle Creek Arbitrage’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-94,384
Closed -$25.1K 16
2023
Q3
$25.1K Sell
94,384
-35,704
-27% -$11.5K 0.01% 125
2023
Q2
$46.5K Sell
130,088
-8,253
-6% -$2.52K 0.01% 184
2023
Q1
$40.1K Hold
138,341
﹤0.01% 235
2022
Q4
$37.4K Hold
138,341
﹤0.01% 295
2022
Q3
$62K Sell
138,341
-100
-0.1% -$59 ﹤0.01% 426
2022
Q2
$70K Sell
138,441
-16,920
-11% -$9.43K ﹤0.01% 424
2022
Q1
$95K Buy
+155,361
New +$84.7K ﹤0.01% 480

Other funds holding DRTSW

Castle Creek Arbitrage's DRTSW Position: Q4 2023 in Review

Castle Creek Arbitrage sold out of Alpha Tau Medical Warrant (DRTSW) in Q4 2023, closing a stake of 94,384 shares — an estimated $25.1K sold.

Castle Creek Arbitrage first reported a position in DRTSW in Q1 2022 and held it in 7 quarters. The position peaked at $95K in Q1 2022. 26 funds tracked by Wall St. Rank hold DRTSW as of Q4 2023.

  • Castle Creek Arbitrage reported no remaining Alpha Tau Medical Warrant position as of Q4 2023 after selling out during the quarter.
  • Castle Creek Arbitrage sold 94,384 Alpha Tau Medical Warrant shares in Q4 2023, an estimated $25.1K.
  • Castle Creek Arbitrage first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 7 quarters.
  • Castle Creek Arbitrage's Alpha Tau Medical Warrant position peaked at $95K in Q1 2022.
  • 26 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q4 2023.

Based on Castle Creek Arbitrage's 13F filing for Q4 2023.